SENSEONICS
Senseonics is a medical device startup company in Germantown, Maryland, USA (near Washington, DC) developing transformative glucose monitoring products that is intended to enable people with diabetes to confidently live their lives with ease. Utilizing breakthrough fluorescence sensing technology, the Senseonics continuous glucose monitoring ("CGM") system is being designed to be the first fully implantable CGM that is highly accurate and stable throughout its long sensor life.
SENSEONICS
Industry:
Biotechnology Health Care Medical Medical Device Sensor Wearables
Founded:
1996-01-01
Address:
Germantown, Maryland, United States
Country:
United States
Website Url:
http://www.senseonics.com
Total Employee:
51+
Status:
Active
Contact:
(301) 515-7260
Total Funding:
455.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Google Tag Manager Google Universal Analytics Domain Not Resolving Mobile Non Scaleable Content Microsoft Exchange Online
Similar Organizations
Active Life Scientific
Active Life Scientific is a medical device company that develops a device for measuring bone quality in patients.
AdHawk Microsystems
AdHawk Microsystems develops camera-free eye-tracking solutions that unlock the connection between the eyes and the brain.
Amedisys
Amedisys is a home health and hospice care company focused on bringing home the continuum of care.
Blue Belt Technologies
Blue Belt Technologies is a medical device company that focuses on technology and capabilities of surgical instrumentation.
BRIUS
BRIUS is a healthcare company that focuses in the orthodontics and medical device industry.
Butterfly Network
Butterfly Network designs a medical imaging device that reduces the cost of real-time and three-dimensional imaging and treatment.
Chronisense Medical
Chronisense Medical offers wearable medical-grade devices designed to monitor vital signs and other health factors.
Delos
Delos is a real estate company that focuses on tech, health, design and science to improve human health in the built environment.
Fresenius Medical Care North America
Fresenius Medical Care North America provides healthcare services to people with renal and other chronic conditions.
Haemonetics
Haemonetics is a provider of blood and plasma supplies and services.
Humacyte
Humacyte develops products for vascular diseases and replacement of anatomical conduits.
Impel NeuroPharma
Impel NeuroPharma is a medical device company that develops a novel drug delivery device that uses direct nose-to-brain delivery.
InspireMD
InspireMD is a medical device company focusing on the development and commercialization of its proprietary stent system technology, MGuard.
K2M
K2M Group Holdings is a medical device company focused on designing, developing and commercializing spine technologies and techniques.
Kromek
Kromek is a supplier of patented radiation detection technologies tothe medical imaging, nuclear detection, and security screening markets.
Medrobotics
Medrobotics is a medical robotics company developing and commercializing the Flex Robotic System.
MIVI Neuroscience
MIVI Neuroscience focuses on developing and commercializing clinical solutions for neurointerventional procedures.
Nemo Healthcare
Nemo Healthcare is a high-tech startup company that focuses on the development of innovative technology for pregnancy monitoring.
Nicast
Nicast engages in the development and commercialization of medical devices made of electrospun polymer nano-fabrics.
OncoHealth
OncoHealth is the leading digital health company focused on navigating the physical, mental and financial complexities of cancer care,
Opsens
Opsens’ high accuracy fiber optic temperature sensor and ultra miniature pressure sensor offer many distinctive advantages for the Life
POLYNEURON
Polyneuron is a pharmaceutical company, committed to the development of a new drug class for the treatment of autoimmune disorders.
Reset Pharmaceuticals
Reset Pharma is a biotechnology company that focuses on the development and commercialization of novel psychedelic treatments.
RxSight
RxSight is a medical device company that offers an intraocular lens and cataract surgery solutions.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
SceneRay
SceneRay is a medical device company dedicated to the design, Development, and distribution of neuromodulation devices.
Spectral AI
Spectral AI specializes in predictive analytics with a platform that uses proprietary artificial intelligence (AI).
CHF Solutions
CHF Solutions is a medical device company that focuses on innovative cardiac assist therapy to treat patients.
Vascular Flow Technologies
Vascular Flow Tech focuses on research, development and commercialization of vascular devices based on new understanding of blood flow.
Know Labs
Know Labs is a non-invasive diagnostic technology platform that uses radio waves to identify and measure molecules in the body.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Masters Capital Management
Masters Capital Management investment in Post-IPO Equity - Senseonics
PHC Holdings
PHC Holdings investment in Post-IPO Equity - Senseonics
PHC Holdings
PHC Holdings investment in Post-IPO Debt - Senseonics
Roche Finance
Roche Finance investment in Post-IPO Equity - Senseonics
New Enterprise Associates
New Enterprise Associates investment in Post-IPO Equity - Senseonics
Oxford Finance LLC
Oxford Finance LLC investment in Post-IPO Debt - Senseonics
Silicon Valley Bank
Silicon Valley Bank investment in Post-IPO Debt - Senseonics
Greenspring Associates
Greenspring Associates investment in Venture Round - Senseonics
Abingworth
Abingworth investment in Venture Round - Senseonics
Anthem Capital Management
Anthem Capital Management investment in Venture Round - Senseonics
Official Site Inspections
http://www.senseonics.com Semrush global rank: 1.27 M Semrush visits lastest month: 23.5 K
- Host name: ec2-52-17-142-199.eu-west-1.compute.amazonaws.com
- IP address: 52.17.142.199
- Location: Dublin Ireland
- Latitude: 53.3338
- Longitude: -6.2488
- Timezone: Europe/Dublin
- Postal: D02
More informations about "Senseonics"
Senseonics - Crunchbase Company Profile & Funding
Senseonics is a medical device startup company in Germantown, Maryland, USA (near Washington, DC) developing transformative glucose monitoring products that is intended to enable people with diabetes to confidently live their lives …See details»
Senseonics, Incorporated - LinkedIn
Senseonics, Inc. is a medical device startup company in Germantown, Maryland, USA (near Washington, DC) developing transformative glucose monitoring products that are intended to …See details»
Investor Relations - Senseonics
Oct 24, 2024 Senseonics Mid-Year 2023 Review. View Shareholder Letter News Releases 10/25/2024 Senseonics Holdings, Inc. Announces $16 Million Registered Direct Offering …See details»
Senseonics Holdings, Inc. (SENS) - Yahoo Finance
Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland. Corporate Governance Senseonics Holdings, Inc.’s ISS Governance QualityScore as of N/A is …See details»
Senseonics - AnnualReports.com
Senseonics Holdings, Inc. is a medical technology company focused on the design, development and commercialization of transformational glucose monitoring products designed to help …See details»
Senseonics Holdings, Inc. (SENS) Company Profile & Overview
Nov 21, 2024 Senseonics Holdings, Inc., a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people …See details»
Senseonics Holdings, Inc. Announces Business Updates - Yahoo …
GERMANTOWN, Md., January 02, 2024--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, …See details»
Senseonics - Funding, Financials, Valuation & Investors - Crunchbase
Senseonics is a medical device startup company that focuses on the design, development, and commercialization of glucose monitoring systems. ... How much funding has this organization …See details»
Senseonics Holdings, Inc. Announces Business Updates
Jan 2, 2024 Senseonics Holdings, Inc. (“Senseonics”) is a medical technology company focused on the development and manufacturing of glucose monitoring products designed to transform …See details»
Senseonics Company Profile - Craft
Aug 14, 2024 Senseonics Holdings is a medical technology company focused on the development and commercialization of glucose monitoring products. Its Eversense and …See details»
Senseonics Announces FDA Approval of the Eversense® E3 …
Feb 11, 2022 We look forward to initiating Eversense E3 sales and believe that, with Ascensia’s newly dedicated CGM commercial organization, the launch of the new 6-month product will …See details»
Senseonics Holdings, Inc. Provides Business Update and Full
Jun 21, 2024 Senseonics Holdings, Inc., a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring …See details»
Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year …
GERMANTOWN, Md., February 29, 2024--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, …See details»
Senseonics Announces Business Updates
Jan 4, 2022 Senseonics Media Contact: Mirasol Panlilio 301-556-1631 [email protected] Contacts Senseonics Investor Contact: Philip Taylor …See details»
Senseonics grows sales in Q4 despite ‘softer demand’ for CGM …
Mar 17, 2023 Senseonics expects global net revenues of $20 million to $24 million this year, representing growth of 22% to 46% over 2022. The company set out longer-term targets on …See details»
Ascensia’s new head of CGM talks plans for a 365-day sensor
Aug 6, 2024 Senseonics submitted data to the FDA earlier this year for the 365-day sensor. It expects to bring the new device to market in the fourth quarter, and to double sales and the …See details»
Senseonics receives FDA clearance for one-year CGM
Sep 17, 2024 Dive Brief: Senseonics and commercial partner Ascensia Diabetes Care received clearance from the Food and Drug Administration for the first implantable glucose sensor that …See details»
Senseonics tips 365-day CGM to double 2025 sales
Jun 25, 2024 Senseonics expects the launch of its 365-day continuous glucose monitor (CGM) implant to help double its user base and sales in 2025, the company said Sunday. The …See details»